Ahead of the much awaited interest rate decision by the FED later on January 29, the Sensex and Nifty closed at their day's high, continuing their winning streak for the

Dr. Reddy’s began their journey as a supplier to Indian drug manufacturing and now they are working as an International pharmaceutical company. The company produced pharmaceutical products and made more

Benchmark indices continued to trade in the positive, driven by positive sentiment following mild US inflation data. Concerns eased about the US Fed's interest rate, as US core inflation data

Equity benchmarks made a positive opening, witnessed range-bound trading, and ended a 4-day losing streak. Data reports showed a drop in consumer price inflation and a rise in direct tax

Global markets experienced significant sell-off, prompting a similar response in domestic markets due to strong US payroll data suggesting fewer rate cuts in 2025. The U.S. Federal Reserve is likely

Indian equity benchmarks experienced a rollercoaster session on the last trading day of the week. Traders stayed away from risky assets ahead of India's Consumer Price Inflation (CPI) data, which

Indian stock market made a flat opening, but overall outlook remains tilted towards a bearish trend. Traders were cautious ahead of TCS Q3 results later today as expectations suggest that

After making a cautious start, markets initially declined, but luster erased losses and held gains till the end of the first trading day of 2025. Government data showed that the

The Nifty experienced its ninth consecutive year of growth, with both the Nifty and Sensex rising nearly 9% and 8%, marking a strong finish for 2024. The broader market took

Indian stock market began the week on a volatile note, gained ground in the first half but faced selling pressure and reversed its trajectory. Markets traded under pressure during the